🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these profiles privately for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with numerous of participants share “before and after” images, injection guides and claims of rapid British shipping. Vendors promote the substance there before directing customers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and pharmacists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.

Several professionals stated the popularity for retatrutide could be connected to the rising cost of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Material Removal

Based on the social media company, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The company said it was committed to maintaining the service safe and investing in strengthening enforcement strategies.

Digital Trading Operations

Investigations also found groups with up to 9,000 members marketing the experimental drug using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, populated with images of slimming results, glowing testimonials and detailed guides for preparing or injecting at home.

Within moments of entering one group, a vendor shared contact information, where most purchases occur. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about weight, health issues or past usage.

Product Details and Pricing

Inside these communities, messages display dark colored parcels with Royal Mail labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors typically sold at £160 for 20mg. When asked how much time a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram stated it regularly monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they can’t verify. Although the research behind retatrutide is valid, these digital versions may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has already seen patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to potentially significant medical dangers”.